Fact CheckerSign in

NCT07553572Recruiting

Remote Monitoring and Symptom Management Digital Application

Pilot Randomized Controlled Trial of a Remote Monitoring and Symptom Management Intervention (ASSIST) Among Patients Receiving Systemic Therapy

Source: ClinicalTrials.gov · Last updated 28 Apr 2026

Brief summary (registry, in English)

The goal of this clinical trial is to learn if an artificial intelligence phone application called ASSIST can help patients receiving cancer treatment. The main question\[s\] it aims to answer are: Is ASSIST feasible for patients (meaning can it be used by patients)? Is ASSIST acceptable to patients (meaning do patients like it)? Researchers will compare the ASSIST phone application to see how it compares to usual clinical care. Participants on the ASSIST arm will use the ASSIST phone application for 12 weeks, and participants in both groups will complete surveys.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
14 Apr 2026
Start date
14 Apr 2026
Primary completion date
30 Nov 2026
Lead sponsor
Patrick C. Johnson, MD
NCT number
NCT07553572

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From 14 Apr 2026 to the primary completion date, 30 Nov 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Cognitive impairment that would interfere with ability to use smartphone application (as assessed by their attending physician)
  • Visual or motor impairment that would prevent smartphone use

Other

  • Expected survival less than 3 months

Who the study is looking for

  • Age 18 years or older
  • Ability to understand English
  • About to begin definitive systemic treatment (or within 4 weeks of beginning treatment) based upon the oncology treatment intent form for a new diagnosis of breast cancer, colorectal cancer, or lymphoma.
  • Expected treatment duration of at least 12 weeks
  • Own or willing to receive a smartphone

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Massachusetts General Hospital
Coordinator of this site? Confirm its status
BostonUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.